Erratum: Preimplantation genetic diagnosis (PGD) for Huntingtons disease: The experience of three European centres (European Journal of Human Genetics (2012) 20 (368-375) DOI: 10.1038/ejhg.2011.202);Preimplantation genetic diagnosis (PGD) for Huntington's disease: The experience of three European centres

European Journal of Human Genetics

Volumn 20, Issue 4, 2012, Pages 368-375

  Van Rij, Maartje C ^a   De Rademaeker, Marjan ^b   Moutou, Céline ^c   Dreesen, Jos C F M ^a   De Rycke, Martine ^b   Liebaers, Inge ^b   Geraedts, Joep P M ^a   De Die Smulders, Christine E M ^a   Viville, Stéphane ^c,d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

delivery rates; exclusion testing; HTT gene; Huntington's disease (HD); preimplantation genetic diagnosis (PGD); prenatal diagnosis

Indexed keywords

ADULT; ARTICLE; CAG REPEAT; EMBRYO; EMBRYO TRANSFER; EUROPE; FEMALE; GENE INSERTION; GENETIC LINKAGE; GENETIC RISK; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; OOCYTE RETRIEVAL; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REPRODUCTIVE HISTORY; SAFETY;

EID: 84858333545     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.122     Document Type: Erratum

References (43)

1. Bates G, Harper P, Jones L: Huntington's Disease. New York: Oxford University Press, 2002.
2. MacDonald ME, Ambrose CM, Duyao MP et al: HDCRG: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
3. Novak MJ, Tabrizi SJ: Huntington's disease. BMJ 2010; 340: C3109.
4. Roos RA: Huntington's disease: A clinical review. Orphanet J Rare Dis 2010; 5: 40.
5. Moutou C, Gardes N, Viville S: New tools for preimplantation genetic diagnosis of Huntington's disease and their clinical applications. Eur J Hum Genet 2004; 12: 1007-1014.
6. Sermon K, De Rijcke M, Lissens W et al: Preimplantation genetic diagnosis for Huntington's disease with exclusion testing. Eur J Hum Genet 2002; 10: 591-598.
7. Sermon K, Goossens V, Seneca S et al: Preimplantation diagnosis for Huntington's disease (HD): Clinical application and analysis of the HD expansion in affected embryos. Prenat Diagn 1998; 18: 1427-1436.
8. Sermon K, Seneca S, De Rycke M et al: PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol 2001; 183 Suppl 1: S77-S85.
9. Harper PS, Sarfarazi M: Genetic prediction and family structure in Huntington's chorea. BMJ (Clin Res Ed) 1985; 290: 1929-1931.
10. Schulman JD, Black SH, Handyside A, Nance WE: Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders. Clin Genet 1996; 49: 57-58.
11. Stern HJ, Harton GL, Sisson ME et al: Non-disclosing preimplantation genetic diagnosis for Huntington disease. Prenat Diagn 2002; 22: 503-507.
12. Braude PR, De Wert GM, Evers-Kiebooms G, Pettigrew RA, Geraedts JP: Non-disclosure preimplantation genetic diagnosis for Huntington's disease: Practical and ethical dilemmas. Prenat Diagn 1998; 18: 1422-1426.
13. Evers-Kiebooms G, Zoeteweij M, Harper PS: Prenatal Testing for Late-Onset Neurogenetic Diseases. Oxford: BIOS Scientific Publishers Ltd, 2002.
14. Dreesen J, Drusedau M, Smeets H et al: Validation of preimplantation genetic diagnosis by PCR analysis: Genotype comparison of the blastomere and corresponding embryo, implications for clinical practice. Mol Hum Reprod 2008; 14: 573-579.
15. Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC: The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod 2009; 24: 1221-1228.
16. Gianaroli L, Plachot M, van Kooij R et al: ESHRE guidelines for good practice in IVF laboratories. Committee of the Special Interest Group on Embryology of the European Society of Human Reproduction and Embryology. Hum Reprod 2000; 15: 2241-2246.
17. Thornhill AR, de Die-Smulders CE, Geraedts JP et al: ESHRE PGD consortium 'best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. Hum Reprod 2005; 20: 35-48.
18. Vandervorst M, Liebaers I, Sermon K et al: Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum Reprod 1998; 13: 3169-3176.
19. Devroey P, Van Steirteghem A: A review of ten years experience of ICSI. Hum Reprod Update 2004; 10: 19-28.
20. De Vos A, Van Steirteghem A: Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 2001; 21: 767-780.
21. Goossens V, De Rycke M, De Vos A et al: Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod 2008; 23: 481-492.
22. Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A: Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: Influence of the fertilization procedure. Fertil Steril 2005; 83: 1397-1403.
23. Sermon K, Van Steirteghem A, Liebaers I: Preimplantation genetic diagnosis. Lancet 2004; 363: 1633-1641.
24. Zegers-Hochschild F, Adamson GD, de Mouzon J et al: The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod 2009; 24: 2683-2687.
25. Bonduelle M, Liebaers I, Deketelaere V et al: Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod 2002; 17: 671-694.
26. Wet betreffende medisch begeleide voortplanting en de bestemming van de overtollige embryo's en gameten (Law concerning assisted reproduction and the handeling of surpluss embryos and gametes). Belgisch Staatsblad 2007; 38575-38586.
27. Regeling van de staatssecretaris van Volksgezondheid, Welzijn en Sport van 16 februari 2009, nr. CZ-TSZ-2912089, houdende regels ten aanzien van preïmplantatie genetische diagnostiek (PGD) (Regeling preïmplantatie genetische diagnostiek) (Regulations of the State Secretary of Health on the rules concerning PGD). Staatscourant 2009; 1-12.
28. Conneally PM: Huntington disease: Genetics and epidemiology. Am J Hum Genet 1984; 36: 506-526.
29. Decruyenaere M, Evers-Kiebooms G, Boogaerts A et al: The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. Eur J Hum Genet 2007; 15: 453-462.
30. Harper JC, Coonen E, De Rycke M et al: ESHRE PGD consortium data collection X: Cycles from January to December 2007 with pregnancy follow-up to October 2008. Hum Reprod 2010; 25: 2685-2707.
31. Jasper MJ, Hu DG, Liebelt J et al: Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington's disease. Fertil Steril 2006; 85: 597-602.
32. Tassicker RJ, Marshall PK, Liebeck TA, Keville MA, Singaram BM, Richards FH: Predictive and prenatal testing for Huntington Disease in Australia: Results and challenges encountered during a 10-year period (1994-2003). Clin Genet 2006; 70: 480-489.
33. Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K: Genetic testing in asymptomatic minors: Background considerations towards ESHG recommendations. Eur J Hum Genet 2009; 17: 711-719.
34. Simpson SA, Zoeteweij MW, Nys K et al: Prenatal testing for Huntington's disease: A European collaborative study. Eur J Hum Genet 2002; 10: 689-693.
35. Craufurd D, Dodge A, Kerzin-Storrar L, Harris R: Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989; 2: 603-605.
36. Creighton S, Almqvist EW, MacGregor D et al: Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: The experience in Canada from 1987 to 2000. Clin Genet 2003; 63: 462-475.
37. Evers-Kiebooms G, Nys K, Harper P et al: Predictive DNA-testing for Huntington's disease and reproductive decision making: A European collaborative study. Eur J Hum Genet 2002; 10: 167-176.
38. Harper PS, Lim C, Craufurd D: Ten years of presymptomatic testing for Huntington's disease: The experience of the UK Huntington's disease prediction consortium. J Med Genet 2000; 37: 567-571.
39. Maat-Kievit A, Vegter-Van Der Vlis M, Zoeteweij M, Losekoot M, van Haeringen A, Roos R: Paradox of a better test for Huntington's disease. J Neurol Neurosurg Psychiatry 2000; 69: 579-583.
40. Adam S, Wiggins S, Whyte P et al: Five year study of prenatal testing for Huntington's disease: Demand, attitudes, and psychological assessment. J Med Genet 1993; 30: 549-556.
41. Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M et al: Experience in prenatal testing for Huntington's disease in the Netherlands: Procedures, results and guidelines (1987-1997). Prenat Diagn 1999; 19: 450-457.
42. Tassicker RJ, Teltscher B, Trembath MK et al: Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17: 66-70.
43. van Rij MC, Gielen M, Lulofs R et al: Profiles and motives for PGD: A prospective cohort study of couples referred for PGD in the Netherlands. Hum Reprod 2011; 26: 1826-1835.